UPC Analytics
ENDE
Overview · Filed: Jun 13, 2024

UPC_CFI_315/2024

MODULAR POINT-OF-CARE DEVICES AND USES THEREOF

InfringementMain Infringement ActionDusseldorf LDInfringementCase Closed
OverviewDecisionsReasoningCitationsDocumentsTimeline
Parties

Claimants

  • Labrador Diagnostics LLC
Reps: Christof Höhne (EIP Europe LLP); Sebastian Fuchs (EIP Europe LLP)

Respondents

  • bioMérieux SA
  • bioMérieux Deutschland GmbH
  • bioMérieux Italia S.p.A.
  • bioMérieux Austria GmbH
  • bioMérieux Portugal, Lda.
  • bioMérieux Benelux BV
Reps: Benjamin Husband (Carpmaels & Ransford LLP); Agathe Michel-De Cazotte (Carpmaels & Ransford LLP)
Judges
  • Ronny Thomas
  • Berenice Thom
  • Mélanie Bessaud
  • Michel Abello
Patents
  • EP3756767
CPC codes: B01L3/021, G01N2333/4737, G01N2035/00851, G01N2333/71, G01N33/48, B01J2219/00292, B01L7/5255, B01L9/543, B01L7/52, A61B5/151, G01N33/54366, A61B10/0058…

Technology area: Medical Devices · Diagnostics

Sector: Biotechnology

Outcome
Not infringedNot infringed
Filed: Jun 13, 2024
First decided: Sep 26, 2025
Last decision: Jan 28, 2026
Language: English

The Düsseldorf Local Division dismissed Labrador Diagnostics' infringement action concerning EP 3 756 767 against bioMérieux entities, finding no infringement after the Central Division amended the patent claims; the court was bound by the amended claim wording and validity was no longer decisive.

Open on UPC Registry
Claims
At issue1, 2
Not infringed1, 2
Notes: Düsseldorf LD dismissed infringement of EP3756767; claim 1 (device) and claim 2 (method) both found not infringed after patent was amended by Central Division in bifurcated proceedings.